Frequency and significance of vascular endothelial growth factor (VEGF) 936 C/T polymorphism in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 417s Year: 2002
Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome Source: Eur Respir J 2003; 22: 335-341 Year: 2003
The impact of genetic and perinatal factors on the development of respiratory distress syndromes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
Expression and significance of chemokine-like factor 1 in the lungs of patients with severe acute respiratory syndrome Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010
Genetic factors in the development of neonatal respiratory distress syndrome in the newborns Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007
Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002
Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome Source: Eur Respir J 2006; 27: 674-681 Year: 2006
Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006
Role of genetic factors in COPD (alpha-1-antitrypsin deficiency and other factors) Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures Year: 2005
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Source: Eur Respir J 2003; 22: 57S-64S Year: 2003
The influence of gene-gene interaction on the development of respiratory distress syndrome in the neonates Source: Annual Congress 2012 - Gene-environment treatment and asthma Year: 2012
Neuregulin-1 as a potentially novel biomarker in acute respiratory distress syndrome Source: Eur Respir J 2013; 41: 259-261 Year: 2013
Angiopoietin like 4 as a clinical biomarker for acute respiratory distress syndrome Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure Year: 2019
Mechanisms of acute lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005
Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness Source: Eur Respir J 2009; 33: 1287-1294 Year: 2009
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance Source: Eur Respir J 2014; 43: 276-285 Year: 2004
The predictive role of inflammatory markers and CD 95 for acute respiratory distress syndrome development and outcome Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006